This site is optimised for modern browsers. For the best experience, please use Google Chrome, Mozilla Firefox, or Microsoft Edge.

Principal Investigator awarded honorary title

Professor Adrian Palfreeman

We’re pleased to announce that one of our principal investigators, Adrian Palfreeman has been awarded the honorary title of Professor by the University of Leicester. Professor Palfreeman is a consultant in infectious diseases at our host Trust, the University Hospitals of Leicester NHS Trust.

Prof Palfreeman is leading a number of studies for the NIHR Patient Recruitment Centre: Leicester, most notably the COVID-19 vaccine trial, ENSEMBLE-2. Under his leadership as the principal investigator, the team delivering the trial in Leicester recruited almost 600 participants within 19 weeks. The initial recruitment target was 350.

Melanie Davies, Professor of Diabetes Medicine at the University of Leicester and Clinical Director of the NIHR Patient Recruitment Centre: Leicester said: “I am very pleased that Adrian has been awarded the well-deserved, honorary title of Professor. Throughout the pandemic he has played an important role in vaccine research in Leicester. We are honoured to have Adrian leading a variety of upcoming studies. This is just one example of how the Patient Recruitment Centres benefit from working with highly experienced NHS clinicians as chief and principal investigators, many of which are world renowned.”

Prof Palfreeman said: “I was delighted and honoured by this news. As so often is the case success is a team effort so my thanks go to the hard working, dedicated and highly-skilled research delivery team at Patient Recruitment Centre: Leicester who supported the recent COVID-19 vaccine trial so brilliantly.”

Read more about Prof Palfreeman's role in vaccine research.